Project Grant R43DA060718
Award Date
7/1/24
Completion Date
6/30/25
Dollars Obligated
$592K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Springfield, OR 97477, USA
Similar Awards
This $304,023 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a digital product called RESHAPE. The objective is to create a comprehensive digital experience that addresses the health-related social needs (HRSN) impacting substance use disorder (SUD) recovery. The project involves formative research, development, and large-scale deployment of the RESHAPE digital platform, which...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Federal Grant Program "Drug Use and Addiction Research Programs" (CFDA 93.279), provides $1,607,146 over 2 years to NDRI-USA Inc., a non-profit research organization based in New York. The funding will support the development of technology-based interventions to encourage drug checking, distribution of harm reduction supplies, and linkage to substance use services. The project aims to address the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $668,110 to Washington State University to refine and assess the feasibility and acceptability of a technology-based intervention for college students. The intervention aims to increase young adults' knowledge of cannabis products, laws, and associated risks, in order to reduce cannabis misuse among college students. The study will involve focus...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,702,558 to Prevention Strategies, LLC to optimize an online behavioral intervention to prevent and reduce substance use among high school seniors. The key objectives are to: 1) Design an initial set of six theory-based online intervention components targeting social influences linked to substance use; 2) Evaluate the effect of each...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $800,000 Project Grant to Tenvos Inc., a minority-owned and woman-owned small business, to develop a software-based medical device for detecting opioid use through voice analysis. The proposed solution will integrate into a smartphone app, enabling patients to test for opioid use remotely from home and securely transmit results to their clinicians, thereby improving...
This $397,829 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Federal Drug Use and Addiction Research Programs (CFDA 93.279), supports the development of an AI platform to accelerate the discovery of therapeutics for substance use disorders (SUDs). The key objectives of this 1-year project are to: 1) create curated datasets and machine learning models to expedite drug discovery tasks, 2) identify mechanistic targets for GLP-1 receptor agonist pathways that can...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $390,000.00 to the Regents of the University of Michigan to pilot an innovative digital Contingency Management (CM) intervention for individuals with co-occurring opioid and alcohol use disorders. The study aims to: 1) identify optimal settings and approaches to engage Medicaid beneficiaries in digital CM through Medicaid claims data...
This $773,241 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under CFDA Program 93.279 (Drug Use and Addiction Research Programs) aims to develop an "Improving Health and Housing Outcomes through a Simulation and Economic Model (IHOUSE Model)." The key products and services to be delivered include: Employing a group model building approach to engage community stakeholders and inform the development of agent-based models simulating health outcomes and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) totaling $1,076,018 aims to conduct a decentralized clinical trial of a contingency management digital therapeutic to treat stimulant use disorder (STUD). The funded project will develop and evaluate DCH-003, a prescription digital therapeutic that delivers contingency management and other evidence-based treatments for STUD through a mobile app. The...
The National Institute on Drug Abuse (NIDA) awarded a $2,164,152 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of Illinois to conduct a hybrid effectiveness-implementation randomized controlled trial (RCT) evaluating the impact of a meditation mobile app on substance use, sexual health, and emotion regulation among youth on probation. The 5-year grant, which began on September 15, 2024, will leverage a prior successful pilot study to test the app's...